How AI Scribes Save Allergists 2 Hours a Day

Allergy is a documentation-heavy specialty

Allergists have one of the most documentation-intensive practices in medicine. A single visit might involve a skin prick test panel with 40 or more allergens, each requiring individual measurement and interpretation. Add immunotherapy build-up schedules, detailed environmental exposure histories, medication cross-references for drug allergies, and the multi-visit longitudinal tracking that allergy care demands, and you start to see the problem.

An average allergy visit generates two to three times the documentation of a primary care encounter. A patient presenting with allergic rhinitis, asthma overlap, and suspected food allergies doesn't just need a quick note. They need structured documentation covering skin test results, pulmonary function data, dietary history, current and past medication trials, and a management plan that spans multiple follow-up visits.

This isn't a complaint about the medicine. It's a reality of the specialty. Allergy care is inherently data-rich, and the documentation has to match. The question is whether the provider has to be the one typing all of it at 9 PM.

The documentation burden

Most allergists spend two to three hours per day on clinical documentation after their last patient leaves. That's not an exaggeration. It's what the data consistently shows, and it's what providers tell us when we talk to them.

The pattern is familiar to anyone in the specialty: clinic ends at 5 PM, but the provider is still charting at 8, 9, sometimes 10 PM. Weekends get consumed by documentation catch-up. The notes pile up because each one takes 10 to 15 minutes to complete properly, and a busy allergist sees 25 to 35 patients a day.

Burnout rates in allergy and immunology are rising. Studies show that documentation burden is the single largest contributor to physician dissatisfaction across specialties, and allergy ranks among the worst offenders because of the sheer volume and complexity of what needs to be recorded. Providers didn't go into medicine to spend their evenings typing. But that's exactly what the current system demands.

Why generic AI scribes fail in allergy

The market is full of AI medical scribes now. Most of them work reasonably well for straightforward primary care encounters. A patient comes in with a sore throat, the AI listens to the conversation, generates a note. Simple enough.

Allergy is a different animal. Generic AI scribes fail in this specialty for several specific reasons:

• They don't understand allergen panel formatting. Skin prick test results need to be documented in a structured grid format with wheal and flare measurements for each allergen. Generic scribes produce narrative text that requires complete reformatting.
• They miss immunotherapy protocol details. Allergy immunotherapy involves precise dose escalation schedules, vial concentrations, injection site reactions, and build-up versus maintenance phase tracking. A scribe that doesn't understand this workflow produces notes that are clinically incomplete.
• They can't handle multi-visit longitudinal context. Allergy care often spans months or years. A useful note needs to reference prior test results, previous medication trials, and the overall trajectory of treatment. Generic scribes treat each visit as isolated.
• They get the terminology wrong. Confusing allergic rhinitis with vasomotor rhinitis, misidentifying cross-reactive allergen families, or failing to distinguish IgE-mediated from non-IgE-mediated reactions. These errors mean providers spend more time editing than they would have spent writing from scratch.
• They don't suggest appropriate allergy-specific codes. ICD-10 coding for allergy is nuanced. There are specific codes for allergic rhinitis due to pollen versus animal dander versus dust mites, and getting this right matters for reimbursement and clinical accuracy.

The result: providers try a generic AI scribe, find that it creates more work than it saves, and go back to charting manually. Not because AI scribes don't work, but because the wrong AI scribe doesn't work for their specialty.

How MedoraMD handles allergy workflows

MedoraMD was built for specialty medicine. That means we didn't take a general-purpose scribe and bolt on a few allergy templates. The system understands allergy-specific clinical workflows from the ground up.

Here's what that looks like in practice:

Specialty-specific templates. When an allergist uses MedoraMD, the system applies documentation templates designed for allergy encounters. Skin test visits, immunotherapy visits, food allergy evaluations, drug allergy assessments, and asthma management visits each have their own structured format. The AI knows what information belongs where.

Automatic skin test result formatting. When a provider dictates or discusses skin prick test results, MedoraMD captures the data and formats it in the structured grid that allergy documentation requires. Wheal and flare measurements are organized by allergen category (trees, grasses, weeds, molds, animals, dust mites) with positive and negative controls documented correctly.

Immunotherapy dose tracking. The system tracks immunotherapy protocols across visits, documenting current vial concentrations, dose volumes, injection site reactions, and build-up schedule progression. When a patient comes in for their weekly shot, MedoraMD already knows where they are in the protocol and what the expected next dose should be.

Proper ICD-10 coding. MedoraMD suggests allergy-specific diagnosis codes based on the clinical encounter. Allergic rhinitis due to pollen (J30.1), allergic rhinitis due to animal hair and dander (J30.81), allergic contact dermatitis due to metals (L23.0) -- the system differentiates between these and suggests the most specific applicable code.

Longitudinal context awareness. The AI references prior visits, previous test results, and the patient's treatment trajectory. When a patient returns for a follow-up, the generated note connects to what happened before. It notes which allergens were positive on prior testing, what medications have been tried and failed, and where the immunotherapy protocol stands.

A day in the life with MedoraMD

Here's what a typical clinic day looks like for an allergist using MedoraMD:

8:00 AM - First patient. A 34-year-old presenting for initial allergy evaluation. The provider takes the history, performs skin prick testing with a 50-allergen panel, and discusses results with the patient. MedoraMD listens to the entire encounter, capturing the environmental history, recording skin test results as they're read aloud, and generating the note in real time. By the time the patient leaves the room, the note is drafted -- complete with structured skin test results, assessment, and a recommended plan including immunotherapy candidacy discussion.

9:15 AM - Immunotherapy follow-up. A patient in the build-up phase of subcutaneous immunotherapy. The provider reviews the injection log, administers the dose, and monitors for 30 minutes. MedoraMD documents the visit with the correct vial concentration, dose volume, injection site, and any local or systemic reaction. It also flags that the patient is due for a dose increase at the next visit per the build-up schedule.

10:30 AM - Asthma and allergy overlap. A complex patient with allergic asthma, chronic rhinosinusitis, and aspirin-exacerbated respiratory disease. MedoraMD captures the spirometry results discussed during the visit, documents the current biologic therapy, and generates a note that properly codes for all three conditions. The provider glances at the note on screen, makes one small edit, and signs it before the next patient walks in.

The pattern continues through the day. Each encounter generates a complete, specialty-appropriate note in real time. The provider reviews and signs notes between patients or during brief pauses. No backlog accumulates.

5:00 PM - Last patient leaves. The provider reviews two remaining notes that needed minor adjustments, signs them, and closes the chart. Total after-hours documentation time: zero. They're home for dinner.

The results

Across allergists using MedoraMD, we see consistent outcomes:

• 2+ hours saved per day on clinical documentation, with most providers reporting they no longer chart after clinic hours
• Notes completed before the next patient, eliminating the end-of-day documentation backlog entirely
• Reduction in coding errors, with more specific ICD-10 codes leading to fewer claim rejections and improved reimbursement accuracy
• Improved documentation completeness, particularly for skin test results and immunotherapy tracking, which are often abbreviated or incomplete in manually written notes
• More time with patients, because providers aren't mentally composing notes during the encounter -- the AI handles that, freeing the provider to focus on the person in front of them

These aren't theoretical projections. They're what allergists using the system report after their first month.

What providers say

The feedback we hear most often isn't about the technology. It's about what the technology gives back.

Providers talk about eating dinner with their families again. About not dreading Monday mornings because there's no documentation backlog from Friday. About actually making eye contact with patients during visits instead of staring at a screen and typing.

One allergist described it simply: before MedoraMD, every patient visit came with a 10-minute documentation tax that had to be paid later. After MedoraMD, the documentation is just done. The tax is gone. Multiply that across 30 patients a day, five days a week, and you get back an entire professional life that was being consumed by the EHR.

Others mention the clinical quality improvement. When the AI produces a structured, complete note in real time, providers catch things they might have missed in a manually written note at 9 PM. Medication interactions get flagged. Prior test results are surfaced. The documentation becomes a clinical tool, not just a billing requirement.

The most common reaction after the first week is disbelief that it actually works for allergy. Providers who tried generic scribes and gave up are surprised that a system built for their specialty handles the complexity correctly. That's not accidental. It's the result of building for specialty medicine from the start.